Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-29 13:46:26 - browse：82

Red blood cells flow in an artery biotech — coverage from STAT — Adobe

PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention, showing potential to be a safer alternative for patients.

Among patients with atrial fibrillation, an abnormal heart rhythm that increases the risk of stroke, abelacimab, developed by Anthos Therapeutics, cut the overall risk of bleeding by 67% compared to rivaroxaban, the blood thinner sold as Xarelto by Janssen Pharmaceuticals.

The treatment, injected monthly, also reduced the risk of major bleeding events by 74% and gastrointestinal bleeding by 93%, according to Phase 2 results presented here Sunday at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Device maker Teleflex to acquire urology company for $600M

WSS

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Yancopoulos of Regeneron works to expand Dupixent success

Biotech investment managers search for lucrative opportunities

Testing GLP

Chinese researcher claims birth of first gene

How doctors’ personal politics affect patients

hotspot

Wikipedia

focus

Guidelines to prevent youth baseball injuries need more muscle

Mirador, a new biotech startup, launches with $400 million

Malaria cases in Florida and Texas: Here’s what you need to know

Bring on the sabbaticals for nurses

Cancer drug shortages should be causing more outrage

Why patients can’t get everything they want on drug pricing

Virginia high school admissions case could be legal follow

Diabetes management: Digital health tools fall short, study says

New air purifier tech could be key to improving indoor air quality

Cancer, immunology, HIV research ensnared in fetal tissue politics

focus

Senate panel puts off hardest PBM reforms for another day

Medical devices makers are asking for forgiveness, not permission

U.K. officials, researchers try to ease path for bespoke genetic treatments

Mirador, a new biotech startup, launches with $400 million

Surgeons perform first xenotransplant using CRISPR'd pig kidney

What it's like to live with paralysis for one psychologist

entertainment

entertainment

hotspot

hotspot